Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target EBA-175

English version České info

Disrupting erythrocyte invasion by Plasmodium falciparum is an attractive approach to combat malaria. P. falciparum EBA-175 (PfEBA-175) engages the host receptor Glycophorin A (GpA) during invasion and is a leading vaccine candidate. Antibodies that recognize PfEBA-175 can prevent parasite growth, although not all antibodies are inhibitory. Here, using x-ray crystallography, small-angle x-ray scattering and functional studies, we report the structural basis and mechanism for inhibition by two PfEBA-175 antibodies. Structures of each antibody in complex with the PfEBA-175 receptor binding domain reveal that the most potent inhibitory antibody, R217, engages critical GpA binding residues and the proposed dimer interface of PfEBA-175. A second weakly inhibitory antibody, R218, binds to an asparagine-rich surface loop. We show that the epitopes identified by structural studies are critical for antibody binding. Together, the structural and mapping studies reveal distinct mechanisms of action, with R217 directly preventing receptor binding while R218 allows for receptor binding. Using a direct receptor binding assay we show R217 directly blocks GpA engagement while R218 does not. Our studies elaborate on the complex interaction between PfEBA-175 and GpA and highlight new approaches to targeting the molecular mechanism of P. falciparum invasion of erythrocytes. The results suggest studies aiming to improve the efficacy of blood-stage vaccines, either by selecting single or combining multiple parasite antigens, should assess the antibody response to defined inhibitory epitopes as well as the response to the whole protein antigen. Finally, this work demonstrates the importance of identifying inhibitory-epitopes and avoiding decoy-epitopes in antibody-based therapies, vaccines and diagnostics.

Vyšlo v časopise: Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target EBA-175. PLoS Pathog 9(5): e32767. doi:10.1371/journal.ppat.1003390
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003390

Souhrn

Zdroje

1. OrlandiPA, KlotzFW, HaynesJD (1992) A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2–3)Gal- sequences of glycophorin A. J Cell Biol 116: 901–909.

2. AdamsJH, SimBK, DolanSA, FangX, KaslowDC, et al. (1992) A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci U S A 89: 7085–7089.

3. CamusD, HadleyTJ (1985) A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 230: 553–556.

4. SimBK, ChitnisCE, WasniowskaK, HadleyTJ, MillerLH (1994) Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264: 1941–1944.

5. SimBK, OrlandiPA, HaynesJD, KlotzFW, CarterJM, et al. (1990) Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion. J Cell Biol 111: 1877–1884.

6. JiangL, GaurD, MuJ, ZhouH, LongCA, et al. (2011) Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine. Proc Natl Acad Sci U S A 108: 7553–7558.

7. OrdRL, RodriguezM, YamasakiT, TakeoS, TsuboiT, et al. (2012) Targeting sialic acid dependent and independent pathways of invasion in Plasmodium falciparum. PLoS One 7: e30251.

8. El SahlyHM, PatelSM, AtmarRL, LanfordTA, DubeT, et al. (2010) Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic. Clin Vaccine Immunol 17: 1552–1559.

9. SimBK, NarumDL, ChattopadhyayR, AhumadaA, HaynesJD, et al. (2011) Delineation of stage specific expression of Plasmodium falciparum EBA-175 by biologically functional region II monoclonal antibodies. PLoS One 6: e18393.

10. CowmanAF, CrabbBS (2006) Invasion of red blood cells by malaria parasites. Cell 124: 755–766.

11. SinnisP, SimBK (1997) Cell invasion by the vertebrate stages of Plasmodium. Trends Microbiol 5: 52–58.

12. SimBK, ToyoshimaT, HaynesJD, AikawaM (1992) Localization of the 175-kilodalton erythrocyte binding antigen in micronemes of Plasmodium falciparum merozoites. Mol Biochem Parasitol 51: 157–159.

13. ToliaNH, EnemarkEJ, SimBK, Joshua-TorL (2005) Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 122: 183–193.

14. OrlandiPA, SimBK, ChulayJD, HaynesJD (1990) Characterization of the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum. Mol Biochem Parasitol 40: 285–294.

15. SinghS, AlamMM, Pal-BhowmickI, BrzostowskiJA, ChitnisCE (2010) Distinct external signals trigger sequential release of apical organelles during erythrocyte invasion by malaria parasites. PLoS Pathog 6: e1000746.

16. OkenuDM, RileyEM, BickleQD, AgomoPU, BarbosaA, et al. (2000) Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect Immun 68: 5559–5566.

17. McCarraMB, AyodoG, SumbaPO, KazuraJW, MoormannAM, et al. (2011) Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria. Pediatr Infect Dis J 30: 1037–1042.

18. RichardsJS, StanisicDI, FowkesFJ, TavulL, DabodE, et al. (2010) Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis 51: e50–60.

19. OsierFH, FeganG, PolleySD, MurungiL, VerraF, et al. (2008) Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 76: 2240–2248.

20. ReedMB, CaruanaSR, BatchelorAH, ThompsonJK, CrabbBS, et al. (2000) Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion. Proc Natl Acad Sci U S A 97: 7509–7514.

21. DuraisinghMT, MaierAG, TrigliaT, CowmanAF (2003) Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc Natl Acad Sci U S A 100: 4796–4801.

22. PerssonKE, McCallumFJ, ReilingL, ListerNA, StubbsJ, et al. (2008) Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest 118: 342–351.

23. PandeyAK, ReddyKS, SaharT, GuptaS, SinghH, et al. (2012) Identification of a Potent Combination of Key Plasmodium Falciparum Merozoite Antigens That Elicit Strain Transcending Parasite Neutralizing Antibodies. Infect Immun 81: 441–51.

24. WilliamsAR, DouglasAD, MiuraK, IllingworthJJ, ChoudharyP, et al. (2012) Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens. PLoS Pathog 8: e1002991.

25. LopatickiS, MaierAG, ThompsonJ, WilsonDW, ThamWH, et al. (2011) Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infect Immun 79: 1107–1117.

26. KainKC, OrlandiPA, HaynesJD, SimKL, LanarDE (1993) Evidence for two-stage binding by the 175-kD erythrocyte binding antigen of Plasmodium falciparum. J Exp Med 178: 1497–1505.

27. LawrenceMC, ColmanPM (1993) Shape complementarity at protein/protein interfaces. J Mol Biol 234: 946–950.

28. PetoukhovMV, SvergunDI (2005) Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys J 89: 1237–1250.

29. FischerH, de Oliveira NetoM, NapolitanoHB, PolikarpovI, CraievichAF (2010) Determination of the molecular weight of proteins in solution from a single small-angle X-ray scattering measurement on a relative scale. Journal of Applied Crystallography 43: 101–109.

30. CohenGH, WilcoxWC, SodoraDL, LongD, LevinJZ, et al. (1988) Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells. J Virol 62: 1932–1940.

31. AmbroggioX, JiangL, AebigJ, ObiakorH, LukszoJ, et al. (2013) The Epitope of Monoclonal Antibodies Blocking Erythrocyte Invasion by Plasmodium falciparum Map to The Dimerization and Receptor Glycan Binding Sites of EBA-175. PLoS One 8: e56326.

32. CromptonPD, PierceSK, MillerLH (2010) Advances and challenges in malaria vaccine development. J Clin Invest 120: 4168–4178.

33. HillAV (2011) Vaccines against malaria. Philos Trans R Soc Lond B Biol Sci 366: 2806–2814.

34. AgnandjiST, LellB, SoulanoudjingarSS, FernandesJF, AbossoloBP, et al. (2011) First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med 365: 1863–1875.

35. WuX, ZhouT, ZhuJ, ZhangB, GeorgievI, et al. (2011) Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333: 1593–1602.

36. AokiST, TraskSD, CoulsonBS, GreenbergHB, DormitzerPR, et al. (2011) Cross-linking of rotavirus outer capsid protein VP7 by antibodies or disulfides inhibits viral entry. J Virol 85: 10509–10517.

37. AokiST, SettembreEC, TraskSD, GreenbergHB, HarrisonSC, et al. (2009) Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 324: 1444–1447.

38. BatchelorJD, ZahmJA, ToliaNH (2011) Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol Biol 18: 908–914.

39. MayerDC, CofieJ, JiangL, HartlDL, TracyE, et al. (2009) Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1. Proc Natl Acad Sci U S A 106: 5348–5352.

40. LinDH, MalpedeBM, BatchelorJD, ToliaNH (2012) Crystal and Solution Structures of Plasmodium falciparum Erythrocyte-binding Antigen 140 Reveal Determinants of Receptor Specificity during Erythrocyte Invasion. J Biol Chem 287: 36830–36836.

41. MalpedeBM, LinDH, ToliaNH (2013) Molecular basis for sialic acid-dependent receptor recognition by Plasmodium falciparum erythrocyte binding antigen 140/BAEBL. J Biol Chem [Epub ahead of print].

42. AndersRF (1986) Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol 8: 529–539.

43. HowardM, NakanishiK, PaulWE (1984) B cell growth and differentiation factors. Immunol Rev 78: 185–210.

44. HoxieJA (2010) Toward an antibody-based HIV-1 vaccine. Annu Rev Med 61: 135–152.

45. PerdomoMF, LeviM, SallbergM, VahlneA (2008) Neutralization of HIV-1 by redirection of natural antibodies. Proc Natl Acad Sci U S A 105: 12515–12520.

46. SteelJ, LowenAC, WangTT, YondolaM, GaoQ, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1: e00018–10.

47. WangTT, TanGS, HaiR, PicaN, NgaiL, et al. (2010) Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A 107: 18979–18984.

48. DouglasAD, WilliamsAR, IllingworthJJ, KamuyuG, BiswasS, et al. (2011) The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun 2: 601.

49. AricescuAR, LuW, JonesEY (2006) A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr 62: 1243–1250.

50. KabschW (2010) Xds. Acta Crystallogr D Biol Crystallogr 66: 125–132.

51. McCoyAJ, Grosse-KunstleveRW, AdamsPD, WinnMD, StoroniLC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658–674.

52. EmsleyP, CowtanK (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126–2132.

53. AdamsPD, Grosse-KunstleveRW, HungLW, IoergerTR, McCoyAJ, et al. (2002) PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr 58: 1948–1954.

54. DavisIW, Leaver-FayA, ChenVB, BlockJN, KapralGJ, et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35: W375–383.

55. EswarN, EramianD, WebbB, ShenMY, SaliA (2008) Protein structure modeling with MODELLER. Methods Mol Biol 426: 145–159.

56. SchroderGF, LevittM, BrungerAT (2010) Super-resolution biomolecular crystallography with low-resolution data. Nature 464: 1218–1222.

57. KrissinelE, HenrickK (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774–797.

58. HuraGL, MenonAL, HammelM, RamboRP, PooleFL2nd, et al. (2009) Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS). Nat Methods 6: 606–612.

59. KonarevPV, VolkovVV, SokolovaAV, KochMHJ, SvergunDI (2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. Journal of Applied Crystallography 36: 1277–1282.

60. SvergunD, BarberatoC, KochMHJ (1995) CRYSOL - a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic Coordinates. Journal of Applied Crystallography 28: 768–773.

61. FrankeD, SvergunDI (2009) DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering. Journal of Applied Crystallography 42: 342–346.

62. VolkovVV, SvergunDI (2003) Uniqueness of ab initio shape determination in small-angle scattering. Journal of Applied Crystallography 36: 860–864.

63. KozinMB, SvergunDI (2001) Automated matching of high- and low-resolution structural models. Journal of Applied Crystallography 34: 33–41.